Skip to main content
. 2017 Jan 12;356:i6681. doi: 10.1136/bmj.i6681

Table 2.

Primary and secondary outcomes, assessed 3.5 years after inclusion in the OPUS II trial and five years after initiation of SEI intervention treatment

Imputed and register data
No of participants OPUS treatment Treatment as usual Estimated mean difference (95% CI) Odds ratio (95% CI) Pdifference
Primary outcome
Negative dimension (mean (SD)) 400 1.72 1.81 −0.10 (−0.33 to 0.13) 0.39
Secondary outcomes
Psychotic dimension (mean (SD)) 400 1.72 1.94 −0.23 (−0.52 to 0.06) 0.12
Remission 400 44 (22.3) 44 (21.7) 1.08 (0.65 to 1.80) 0.76
Suicidal ideation 400 58 (29.4) 69 (34.0) 0.80 (0.50 to 1.30) 0.37
Substance abuse* 400 33 (16.8) 35 (17.2) 0.95 (0.53 to 1.72) 0.87
Compliance with medical treatment† 229 89 (83) 97 (79) 1.34 (0.61 to 3.0) 0.47
Client satisfaction (mean (SD)) 400 27.0 24.4 2.57 (1.36 to 3.79) <0.001
No of months employed (mean (SD))‡ 400 8.8 (14.1) 9.0 (14.0) −0.11 (−2.67 to 2.44) 0.93
No of bed days (mean per year (SD))‡ 400 9.1 (21.9) 11.8 (34.1) −2.79 (−8.40 to 2.82) 0.33
Adherence to treatment§ 319 142 (90.4) 90 (55.6) 8.6 (4.5 to 16) <0.001

Data are number (%) of participants unless stated otherwise. OPUS treatment=psychosocial treatment programme (specialised early intervention) provided to all patients diagnosed with a schizophrenia spectrum disorder in Denmark, column named OPUS show participants randomised to five years of OPUS treatment; SD=standard deviation.

*Fulfilling criteria for harmful use or dependency syndrome diagnosed, ICD-10 (F1x.1 and F1x.2).

†Only analysed for participants receiving treatment with antipsychotic drugs.

‡Data based on registers and therefore not imputed.

§Outcome was operationalised as participants were still in contact with specialised psychiatric services at the time of follow-up interview. Data were obtained with a combination of registers and medical files, and therefore not imputed and only analysed for participants from Copenhagen.